Detalhe da pesquisa
1.
The Ratio of Peripheral Regulatory T Cells to Lox-1+ Polymorphonuclear Myeloid-derived Suppressor Cells Predicts the Early Response to Anti-PD-1 Therapy in Patients with Non-Small Cell Lung Cancer.
Am J Respir Crit Care Med
; 199(2): 243-246, 2019 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30339766
2.
Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer.
Genome Med
; 12(1): 22, 2020 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32111241
3.
Tumor-Infiltrating Regulatory T-cell Accumulation in the Tumor Microenvironment Is Mediated by IL33/ST2 Signaling.
Cancer Immunol Res
; 8(11): 1393-1406, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32878747
4.
Peripheral natural killer cells and myeloid-derived suppressor cells correlate with anti-PD-1 responses in non-small cell lung cancer.
Sci Rep
; 10(1): 9050, 2020 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32493990
5.
Role of myeloid-derived suppressor cells in immune checkpoint inhibitor therapy in cancer.
Arch Pharm Res
; 42(7): 560-566, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31147902
6.
TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM.
Oncoimmunology
; 7(8): e1466769, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30221069